Oxysophoridine rescues spinal cord injury via anti‑inflammatory, anti‑oxidative stress and anti‑apoptosis effects

  • Authors:
    • Zhong Cao
    • Liang Chen
    • Yanbin Liu
    • Tao Peng
  • View Affiliations

  • Published online on: November 28, 2017     https://doi.org/10.3892/mmr.2017.8170
  • Pages: 2523-2528
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Oxysophoridine (OSR) is an alkaloid extracted from Sophora alopecuroides L and has various pharmacological activities. The present study aimed to investigate the protective effects and underlying mechanisms of OSR on spinal cord injury (SCI), a clinically common serious trauma, in a rat model. The results of the present study demonstrated that the anti‑inflammatory effect of OSR improved Basso, Beatie and Bresnahan Locomotor Rating Scale scores and reduced spinal cord tissue water contents in an SCI rat model. Inflammatory activation was measured by ELISA, and Prostaglandin E2 (PGE2), intercellular adhesion molecule‑1 (ICAM‑1), cyclooxygenase‑2 (COX‑2), nuclear factor‑κB (NF‑κB) and B‑cell lymphoma 2 (Bcl‑2)/Bcl‑2‑associated X (Bax) protein expression levels using western blotting. The results revealed that treatment with OSR reduced tumor necrosis factor‑α, interleukin (IL)‑1β, IL‑6, IL‑8 and malondialdehyde, and increased superoxide dismutase and glutathione peroxidase levels in the serum of an SCI rat model. OSR significantly reduced the protein expression of inflammation‑associated proteins PGE2, ICAM‑1, COX‑2, NF‑κB and Bcl‑2/Bax ratio in the spinal cord tissue of an SCI rat model. Furthermore, the results of the current study demonstrate that OSR ameliorates SCI via anti‑inflammatory, anti‑oxidative stress and anti‑apoptosis effects.

Introduction

Spinal cord injury (SCI) is a clinically common serious trauma. The occurrence rate has the tendency to rise with increases in annual traffic accidents (1,2). Furthermore, SCI has a characteristically high disability rate and low mortality, which burden society and individuals (2). Pathophysiological changes of SCI are divided into primary mechanical damage and secondary damage that occurs subsequent to primary damage (3). When primary mechanical damage occurs in SCI, the degree of damage is directly associated with the degree of damaged spinal cord tissue. Clinical intervention in SCI is currently difficult (4). At present, SCI treatment primarily aims to cure secondary damage, prevent further intensification of secondary damage and recover spinal cord functions (5).

Secondary SCI is further damage that is caused by various factors following primary damage of spinal cord. The mechanism is extremely complicated (6). A series of neurobiochemical, microcirculatory and inflammatory responses continue to occur within the damage zone of SCI, which results in local vasospasm, coagulation and thrombogenesis (7). A series of pathological reactions damage persistent nerve cells and also cause damage to spinal cord tissue (8). Currently, it is considered that the mechanisms implicated in secondary SCI primarily include blood vessels, oxidative stress, inflammatory responses and apoptosis (3,9).

The membrane structure of spinal cord tissues contains abundant lipids. Following damage, the generation and release of oxygen radicals is increased. Oxygen radicals act on the polyunsaturated fatty acids of the cytomembrane to generate lipid peroxidase, change membrane permeability, disintegrate lysosomes and cause necrocytosis, which results in secondary damage of the spinal cord. Free radical scavenging in cells primarily involves two antioxidant systems, including enzymatic defense reactions superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) (10).

SCI is the continuous destruction of the spinal canal caused by external force, fracture or instant damage of the spinal cord caused by dislocation upon trauma and is the opposite to physical trauma (11). Secondary damage is further injury to the spinal cord, which is caused by a series of biochemical reaction events, including bleeding, edema, local ischemia reperfusion, inflammatory response, Ca2+ overflow and reactive oxide species after the primary damage has occurred (11). The degree of damage in secondary SCI far exceeds primary damage and is the principal factor for resulting neuronal death and neurofunction deficit (12). SCI is associated with local microcirculation disturbance, damage induced by neuroinflammation and reactive oxygen species, and toxic effects induced by excitatory amino acids, electrolyte imbalance and nerve cell apoptosis (13). Spinal nerve cell apoptosis caused by a series of immune-inflammatory responses is considered to be a major factor involved in the aggravation of secondary damage of the spinal cord. Therefore, the development of methods to preventing secondary damage in the spinal cord after primary damage has occurred is required (13).

The pharmacological action of oxysophoridine (OSR), whose chemical structure is presented in Fig. 1 (14). OSR belongs to the quinolizidine alkaloid group as do other alkaloids of Sophora alopecuroides (14). A previous study demonstrated that OSR has various pharmacological actions, including antiarrhythmic, protection of cardiac muscle, antiviral, antineoplastic effects (15). Furthermore, OSR has antiviral pharmacological actions, which is similar to sophoridine. OSR exhibits anti-inflammatory action and inhibits the biosynthesis of leukotriene B4 (16). The present study hypothesizes that the anti-inflammatory effect of OSR rescues SCI via anti-inflammatory, anti-oxidative stress and anti-apoptosis effects.

Materials and methods

Animals

The experimental protocol was approved by Shandong Provincial Hospital Affiliated to Shandong University Animal Care and Ethics Committee. Female adult Sprague-Dawley rats (weight, 200–230 g, n=50) were purchased from the Experimental Animal Center of Shandong University, and maintained in standard cages (22–24°C and 55–60% humidity) with water and food ad libitum and a 12-h light/dark cycle. All rats were randomly assigned into five groups; sham-operation group, SCI model group, 60 mg/kg OSR group, 120 mg/kg OSR group and 180 mg/kg OSR group. Anesthetized Sprague-Dawley rats received a midline 150 kdyne contusion injury in spinal level T10 using an Infinite Horizon impactor device, which was considered to be the SCI model. The establishment of the SCI model was confirmed by analysis of the Basso, Beatie and Bresnahan (BBB) Locomotor Rating Scale (17) and spinal cord tissue water content. In the 60, 120 and 180 mg/kg OSR groups, SCI rats were administered intragastrically with 60, 120 and 180 mg/kg OSR once per day for 10 days. OSR was purchased from Jinghua Pharmaceutical Group Co., Ltd. (Yanchi, China). In sham-operation group and SCI model group, rats were administered normal saline intragastrically.

Behavioral assessments

Functional recovery was assessed following treatment with OSR using the BBB Locomotor Rating Scale to ensure consistency of the lesion (17). Following 10 days treatment with OSR, the rats were narcotized with 35 mg/kg of pentobarbital and then sacrificed using decollation. Subsequently, abdomen of rats was cut open, spinal level T10 was peeled and spinal cord tissues were collected and washed with PBS. Spinal cord tissues were weighed as wet weight and heated at 80°C for 48 h, and subsequently weighed as dry weight. Spinal cord tissue water content was calculated by (wet weight/dry weight) ×100.

Inflammatory activation as measured by ELISA

Whole blood (500 µl) was centrifuged at 2,000 × g for 10 min at 4°C and serum was collected in every rat to determine the levels of tumor necrosis factor-α (TNF-α; H052), interleukin (IL)-1β (H002), IL-6 (H007), IL-8 (H008), malondialdehyde (MDA; A003-1), SOD (A001-1) and GSH-Px (A005) using commercial ELISA kits from Nanjing Jiancheng Biology Engineering Institute (Nanjing, China) according to the manufacturer's protocol.

Western blotting

Spinal cord tissues were isolated from every rat and homogenized in RIPA assay (Beyotime Institute of Biotechnology, Haimen, China). Protein concentrations were measured using a BCA protein assay kit (Beyotime Institute of Biotechnology, Haimen, China). Proteins (50–80 µg) were fractionated by 12% SDS-PAGE and transferred to a nitrocellulose membrane. The membranes were blocked in 5% skim milk in TBS-Tween-20 (TBS-T; 0.05%) at room temperature for 1 h on a shaker and incubated with the following primary antibodies: Prostaglandin E2 (PGE2; sc-20771; 1:500), intercellular adhesion molecule-1 (ICAM-1; sc-7891; 1:500), cyclooxygenase-2 (COX-2; sc-7951; 1:500), nuclear factor-κB (NF-κB; sc-109; 1:500), Bcl-2-associated X (Bax; sc-6236; 1:500), Bcl-2 (sc-783; 1:500) and GAPDH (sc-367714; 1:500; all from Santa Cruz Biotechnology, Inc., Dallas, TX, USA) at 4°C overnight. The membrane was washed with TBS-T and treated with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:3,000), visualized with a BeyoECL Star (Beyotime Institute of Biotechnology) and quantified using Bio-Rad Laboratories Quantity One software version 3.0 (Bio-Rad Laboratories, Inc., Hercules, CA, USA).

Statistical analysis

Data are presented as the mean ± standard deviation using SPSS version 17.0 (SPSS, Inc., Chicago, IL, USA). Statistical differences were determined using one-way ANOVA followed by a Tukey test. P<0.05 was considered to indicate a statistically significant difference.

Results

OSR rescues BBB scores and reduces spinal cord tissue water content in SCI rats

The BBB scores in the SCI model group were significantly reduced, compared with the sham group (Fig. 2A). Furthermore, treatment with OSR (120 or 180 mg/kg) significantly increased the BBB scores in SCI rats, compared with the SCI model group (Fig. 2A). Inversely, the spinal cord tissue water content of the SCI model group was significantly higher compared with the sham group (Fig. 2B), and 120 or 180 mg/kg of OSR significantly inhibited the increased water content of SCI model rats, compared with the SCI model group (Fig. 2B).

OSR suppresses inflammation in SCI rats

The present study confirmed the anti-inflammatory effect of OSR on inflammation in SCI rats by measuring the levels of TNF-α, IL-1β, IL-6 and IL-8 in the serum using ELISA kits. The results indicate that TNF-α, IL-1β, IL-6 and IL-8 levels in SCI model rats were significantly higher compared with levels in the sham group (Fig. 3). After 10 days of treatment with 120 or 180 mg/kg OSR, serum TNF-α, IL-1β, IL-6 and IL-8 levels in SCI rats were significantly reduced compared with levels in the SCI model group (Fig. 3).

OSR suppresses oxidative stress in SCI rats

To confirm the anti-oxidative stress effect of OSR in SCI rats, the levels of MDA, SOD and GSH-Px in the serum were measured using ELISA kits. Compared with the sham group, MDA levels were significantly increased, and SOD and GSH-Px activities were significantly reduced in SCI model rats (Fig. 4). Treatment with 120 or 180 mg/kg OSR significantly reduced MDA levels, and increased SOD and GSH-Px levels in SCI rats compared with the SCI model group (Fig. 4).

Anti-inflammatory effect of OSR suppresses PGE2 protein expression in SCI rats

PGE2 protein expression in the spinal cord tissue of SCI model rats was significantly higher compared with the sham group (Fig. 5A and B). Treatment with 120 or 180 mg/kg OSR significantly suppressed PGE2 protein expression in SCI rats compared with the SCI model group (Fig. 5A and B).

Anti-inflammatory effect of OSR suppresses ICAM-1 protein expression in SCI rats

The ICAM-1 protein expression in the spinal cord tissue of SCI model rats was significantly increased compared with the sham group (Fig. 5A and C). Administration of 120 or 180 mg/kg OSR significantly reduced the induction of ICAM-1 protein expression in SCI rats compared with the SCI model group (Fig. 5A and C).

Anti-inflammatory effect of OSR suppresses COX-2 protein expression in SCI rats

As demonstrated in Fig. 5A and D, the COX-2 protein expression in the spinal cord tissue of SCI model rats was significantly increased compared with the sham group. Furthermore, treatment with 120 or 180 mg/kg OSR significantly suppressed COX-2 protein expression compared with the SCI model group (Fig. 5A and D).

Anti-inflammatory effect of OSR suppresses NF-κB protein expression in SCI rats

To investigate the involvement of the NF-κB pathway in the anti-inflammatory effect of OSR in SCI rats, NF-κB protein expression in the spinal cord tissue was measured using western blotting. SCI significantly induced NF-κB protein expression compared with the sham group (Fig. 6A and B). Treatment with 120 or 180 mg/kg OSR significantly inhibited the NF-κB protein expression induced by SCI, compared with the SCI model group (Fig. 6A and B).

OSR suppresses the Bax/Bcl-2 protein expression ratio in SCI rats

To investigate the effect of OSR on apoptosis in the SCI rat model, the Bax/Bcl-2 protein expression ratio in the spinal cord tissue of rats was measured by western blotting. The ratio of Bax/Bcl-2 protein expression in SCI model rats was significantly higher compared with the sham group (Fig. 6A and C). However, treatment with 120 or 180 mg/kg OSR significantly reduced the ratio of Bax/Bcl-2 protein expression in SCI model rats, compared with the SCI model group (Fig. 6A and C).

Discussion

Pathophysiological changes in SCI are divided into primary mechanical damage and secondary damage that occurs subsequent to primary damage (1). When primary damage occurs in SCI, it is impossible to intervene clinically, and, currently, treatment of SCI only aims to cure secondary damage (18). Secondary damage of the spinal cord is further injury to the spinal cord that is caused by various factors following primary damage of the spinal cord (19). Spinal damage that results from secondary damage may greatly exceed primary damage. A recent study has investigated the mechanism of SCI, and the mechanisms that are thought to be involved include oxidative stress, inflammatory responses and apoptosis (8). The results of the present study demonstrated that OSR increased BBB scores and reduced spinal cord water content in SCI model rats. These results are similar to the Yang et al (16) which demonstrated that OSR presents effective antinociception in the spinal cord of mice.

A previous study demonstrated that inflammatory responses have an important role on the pathogenesis of secondary damage (20). Another previous study indicated that there is a high number of various types of inflammation-associated proteins in the tissue following spinal cord damage, including TNF-α, IL-1β, IL-6, IL-8, ICAM-1 and vascular cell adhesion molecule 1 (VCAM-1), suggesting that they may have an important role in the pathophysiological mechanism of secondary damage following SCI (10). The results of the current study demonstrate that treatment with OSR suppressed TNF-α, IL-1β, IL-6 and IL-8 levels in SCI model rats. Previously, Meng et al (15) demonstrated that OSR attenuated acute myocardial infarction through anti-oxidative, anti-inflammatory and anti-apoptotic pathways.

SOD has an important role in the oxidation and antioxidant balance, and scavenges free radicals and protect cells from damage (21). MDA is the lipolysis product of lipid peroxidase. The body can generate oxygen radicals through the enzyme system (12), which can attach polyunsaturated fatty acids to the biological membrane, causing lipid peroxidation, forming MDA from lipid peroxide, and causing cell damage. Measurement of MDA is often coordinated with measurement of SOD (21). The level of activity of SOD indicates the ability of the body to scavenge free radicals directly. GSH-Px is an important peroxidase enzyme that is expressed throughout the body (12). GSH-Px eliminates harmful peroxide metabolites in cells and intercepts lipid peroxidation chain reactions, which protects cytomembrane structure (21). The results of the present study indicate that OSR significantly reduced MDA levels, and increased SOD and GSH-Px levels in SCI model rats. This anti-oxidative stress effect of OSR was also reported in a study by Meng et al (15), which demonstrated that OSR attenuated acute myocardial infarction through anti-oxidative, anti-inflammatory and anti-apoptotic pathways.

NF-κB is a transcription factor that has an important regulatory role in inflammatory responses, immune responses, cell growth, differentiation and apoptosis (22). NF-κB consists of p65 and p50 subunits, which combine to form a heterodimer. Activated NF-κB participates in multiple inflammatory cell factors individually or cooperates with other transcription factors, including TNF-α, IL-1β, IL-6, IL-8, ICAM-1 and VACM-1 (13). The gene products induced by NF-κB action further participate in inflammatory and immune responses, and have important functions in physiological and pathological conditions of the body (23). The current study demonstrated that OSR significantly suppressed PGE2, ICAM-1 and COX-2 protein expression in the spinal cord tissue of SCI model rats. Wang et al (24) also reported that OSR protected against ischemia-induced injury via PGE2, COX-2 and ICAM-1 expression, and the NF-κB pathway.

The inflammatory response is one of primary mechanisms of aggravating secondary SCI. The process is primarily induced by the toll-like receptor (TLR)-NF-κB signaling pathways (25). Knowledge of the signal transduction process associated with TLRs-NF-κB signaling is largely based on the investigation of TLR2 and TLR4 (26). Activated TLRs not only induce inflammatory responses, but also promote the differentiation and maturity of antigen-specificity acquired immune responses (26). The present study demonstrated that OSR significantly inhibited NF-κB protein expression in SCI model rats. Wang et al (24) also reported that effects on the NF-κB pathway were associated with the anti-inflammatory effects of OSR, which protected against ischemia-induced injury.

Bcl-2 is a cytoplasmic protein that has a higher level of expression during development of the central nervous system (27). Once development of the nervous system is complete, Bcl-2 expression is maintained at a low level. Bcl-2 is an anti-apoptotic gene and can prevent various apoptosis pathways following spinal damage (21). Previous research has demonstrated that overexpression of Bcl-2 in experimental animals alleviated nerve injury, improved the anti-injury function of the tissue, promoted outward growth of axons, repaired damaged central nervous system tissue and prevented nerve cell apoptosis (28). Bax is located in the cytoplasm. After receiving an apoptosis signal, it is activated to alter the membrane permeability of the mitochondrial membrane and promote the apoptosis of cells (28). The current study demonstrated that OSR significantly reduced the Bax/Bcl-2 protein expression ratio in SCI model rats. Wang et al (29) previously reported that OSR also protects against focal cerebral ischemic injury via Bax/Bcl-2 expression.

In summary, OSR rescues SCI as treatment with OSR increased BBB scores, reduced spinal cord tissue water content, reduced the production of pro-inflammatory cytokines, increased the levels of anti-oxidant enzymes and reduced the ratio of Bax/Bcl-2 protein expression in SCI model rats, which revealed anti-inflammatory, anti-oxidative stress and anti-apoptosis effects of OSR that may be mediated via NF-κB and the Bax/Bcl-2 pathway. In conclusion, OSR may exert a protective effect on SCI by anti-inflammatory, anti-oxidative stress and anti-apoptosis effects, which indicates that OSR may be a potential therapeutic agent for SCI.

References

1 

Jones ML, Evans N, Tefertiller C, Backus D, Sweatman M, Tansey K and Morrison S: Activity-based therapy for recovery of walking in individuals with chronic spinal cord injury: Results from a randomized clinical trial. Arch Phys Med Rehabil. 95:2239–2246 e2. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Richards JS, Bombardier CH, Wilson CS, Chiodo AE, Brooks L, Tate DG, Temkin NR, Barber JK, Heinemann AW, McCullumsmith C and Fann JR: Efficacy of venlafaxine XR for the treatment of pain in patients with spinal cord injury and major depression: A randomized, controlled trial. Arch Phys Med Rehabil. 96:680–689. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Spinu A, Onose G, Daia C, Panţu C, Anghelescu A, Onose L and Mihăescu A: Intermittent catheterization in the management of post spinal cord injury (SCI) neurogenic bladder using new hydrophilic, with lubrication in close circuit devices-our own preliminary results. J Med Life. 5:21–28. 2012.PubMed/NCBI

4 

D'Amico JM, Li Y, Bennett DJ and Gorassini MA: Reduction of spinal sensory transmission by facilitation of 5-HT1B/D receptors in noninjured and spinal cord-injured humans. J Neurophysiol. 109:1485–1493. 2013. View Article : Google Scholar : PubMed/NCBI

5 

Allison DJ and Ditor DS: Targeting inflammation to influence mood following spinal cord injury: A randomized clinical trial. J Neuroinflammation. 12:2042015. View Article : Google Scholar : PubMed/NCBI

6 

Li XQ, Lv HW, Wang ZL, Tan WF, Fang B and Ma H: MiR-27a ameliorates inflammatory damage to the blood-spinal cord barrier after spinal cord ischemia: Reperfusion injury in rats by downregulating TICAM-2 of the TLR4 signaling pathway. J Neuroinflammation. 12:252015. View Article : Google Scholar : PubMed/NCBI

7 

Jiang W, Li M, He F, Bian Z, Liu J, He Q, Wang X, Sun T and Zhu L: Dopamine D1 receptor agonist A-68930 inhibits NLRP3 inflammasome activation and protects rats from spinal cord injury-induced acute lung injury. Spinal Cord. 54:951–956. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Jiang Y, Gong FL, Zhao GB and Li J: Chrysin suppressed inflammatory responses and the inducible nitric oxide synthase pathway after spinal cord injury in rats. Int J Mol Sci. 15:12270–12279. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Ellenbroek D, Kressler J, Cowan RE, Burns PA, Mendez AJ and Nash MS: Effects of prandial challenge on triglyceridemia, glycemia, and pro-inflammatory activity in persons with chronic paraplegia. J Spinal Cord Med. 38:468–475. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Gökce EC, Kahveci R, Gökce A, Cemil B, Aksoy N, Sargon MF, Kısa Ü, Erdoğan B, Güvenç Y, Alagöz F and Kahveci O: Neuroprotective effects of thymoquinone against spinal cord ischemia-reperfusion injury by attenuation of inflammation, oxidative stress, and apoptosis. J Neurosurg Spine. 24:949–959. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Liu G, Zhao J, Chang Z and Guo G: CaMKII activates ASK1 to induce apoptosis of spinal astrocytes under oxygen-glucose deprivation. Cell Mol Neurobiol. 33:543–549. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Fan LH, Wang KZ, Cheng B, Wang CS and Dang XQ: Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following spinal cord ischemia in rabbits. BMC Neurosci. 7:482006. View Article : Google Scholar : PubMed/NCBI

13 

Yarar-Fisher C, Bickel CS, Kelly NA, Stec MJ, Windham ST, McLain AB, Oster RA and Bamman MM: Heightened TWEAK-NF-kB signaling and inflammation-associated fibrosis in paralyzed muscles of men with chronic spinal cord injury. Am J Physiol Endocrinol Metab. 310:E754–E761. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Rui C, Yuxiang L, Ning J, Ningtian M, Qingluan Z, Yinju H, Ru Z, Lin M, Tao S and Jianqiang Y: Anti-apoptotic and neuroprotective effects of oxysophoridine on cerebral ischemia both in vivo and in vitro. Planta Med. 79:916–923. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Meng C, Liu C, Liu Y and Wu F: Oxysophoridine attenuates the injury caused by acute myocardial infarction in rats through anti-oxidative, anti-inflammatory and anti-apoptotic pathways. Mol Med Rep. 11:527–532. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Yang G, Gao J, Jia Y, Yan L, Yu J and Jiang Y: Oxysophoridine through intrathecal injection induces antinociception and increases the expression of the GABAAα1 receptor in the spinal cord of mice. Planta Med. 78:874–880. 2012. View Article : Google Scholar : PubMed/NCBI

17 

Han D, Chen S, Fang S, Liu S, Jin M, Guo Z, Yuan Y, Wang Y, Liu C and Mei X: The Neuroprotective effects of muscle-derived stem cells via brain-derived neurotrophic factor in spinal cord injury model. Biomed Res Int. 2017:19726082017. View Article : Google Scholar : PubMed/NCBI

18 

Jan YK, Liao F, Jones MA, Rice LA and Tisdell T: Effect of durations of wheelchair tilt-in-space and recline on skin perfusion over the ischial tuberosity in people with spinal cord injury. Arch Phys Med Rehabil. 94:667–672. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Leitner L, Walter M, Freund P, Mehnert U, Michels L, Kollias S and Kessler TM: Protocol for a prospective magnetic resonance imaging study on supraspinal lower urinary tract control in healthy subjects and spinal cord injury patients undergoing intradetrusor onabotulinumtoxinA injections for treating neurogenic detrusor overactivity. BMC Urol. 14:682014. View Article : Google Scholar : PubMed/NCBI

20 

Wanner IB, Anderson MA, Song B, Levine J, Fernandez A, Gray-Thompson Z, Ao Y and Sofroniew MV: Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J Neurosci. 33:12870–12886. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Luo Y, Fu C, Wang Z, Zhang Z, Wang H and Liu Y: Mangiferin attenuates contusive spinal cord injury in rats through the regulation of oxidative stress, inflammation and the Bcl2 and Bax pathway. Mol Med Rep. 12:7132–7138. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Wang S, Liu K, Seneviratne CJ, Li X, Cheung GS, Jin L, Chu CH and Zhang C: Lipoteichoic acid from an Enterococcus faecalis clinical strain promotes TNF-α expression through the NF-κB and p38 MAPK signaling pathways in differentiated THP-1 macrophages. Biomed Rep. 3:697–702. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Machova Urdzikova L, Karova K, Ruzicka J, Kloudova A, Shannon C, Dubisova J, Murali R, Kubinova S, Sykova E, Jhanwar-Uniyal M and Jendelova P: The anti-inflammatory compound curcumin enhances locomotor and sensory recovery after spinal cord injury in rats by immunomodulation. Int J Mol Sci. 17:pii: E492015. View Article : Google Scholar

24 

Wang YS, Li YX, Zhao P, Wang HB, Zhou R, Hao YJ, Wang J, Wang SJ, Du J, Ma L, et al: Anti-inflammation effects of oxysophoridine on cerebral ischemia-reperfusion injury in mice. Inflammation. 38:2259–2268. 2015. View Article : Google Scholar : PubMed/NCBI

25 

Li XQ, Lv HW, Tan WF, Fang B, Wang H and Ma H: Role of the TLR4 pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia/reperfusion injury in rats. J Neuroinflammation. 11:622014. View Article : Google Scholar : PubMed/NCBI

26 

Zhang YK, Liu JT, Peng ZW, Fan H, Yao AH, Cheng P, Liu L, Ju G and Kuang F: Different TLR4 expression and microglia/macrophage activation induced by hemorrhage in the rat spinal cord after compressive injury. J Neuroinflammation. 10:1122013. View Article : Google Scholar : PubMed/NCBI

27 

Shibata M, Murray M, Tessler A, Ljubetic C, Connors T and Saavedra RA: Single injections of a DNA plasmid that contains the human Bcl-2 gene prevent loss and atrophy of distinct neuronal populations after spinal cord injury in adult rats. Neurorehabil Neural Repair. 14:319–330. 2000. View Article : Google Scholar : PubMed/NCBI

28 

Chen MH, Ren QX, Yang WF, Chen XL, Lu C and Sun J: Influences of HIF-lα on Bax/Bcl-2 and VEGF expressions in rats with spinal cord injury. Int J Clin Exp Pathol. 6:2312–2322. 2013.PubMed/NCBI

29 

Wang TF, Lei Z, Li YX, Wang YS, Wang J, Wang SJ, Hao YJ, Zhou R, Jin SJ, Du J, et al: Oxysophoridine protects against focal cerebral ischemic injury by inhibiting oxidative stress and apoptosis in mice. Neurochem Res. 38:2408–2417. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

February-2018
Volume 17 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cao Z, Chen L, Liu Y and Peng T: Oxysophoridine rescues spinal cord injury via anti‑inflammatory, anti‑oxidative stress and anti‑apoptosis effects. Mol Med Rep 17: 2523-2528, 2018
APA
Cao, Z., Chen, L., Liu, Y., & Peng, T. (2018). Oxysophoridine rescues spinal cord injury via anti‑inflammatory, anti‑oxidative stress and anti‑apoptosis effects. Molecular Medicine Reports, 17, 2523-2528. https://doi.org/10.3892/mmr.2017.8170
MLA
Cao, Z., Chen, L., Liu, Y., Peng, T."Oxysophoridine rescues spinal cord injury via anti‑inflammatory, anti‑oxidative stress and anti‑apoptosis effects". Molecular Medicine Reports 17.2 (2018): 2523-2528.
Chicago
Cao, Z., Chen, L., Liu, Y., Peng, T."Oxysophoridine rescues spinal cord injury via anti‑inflammatory, anti‑oxidative stress and anti‑apoptosis effects". Molecular Medicine Reports 17, no. 2 (2018): 2523-2528. https://doi.org/10.3892/mmr.2017.8170